BOZEMAN, MT, and VANCOUVER, BC--(Marketwired - August 04, 2016) - Microbion Corporation ("Microbion") of Bozeman, MT, USA and Microbion Pharma Corp. of Vancouver, BC, Canada, specializing in the ...
BOZEMAN, MT and VANCOUVER, BC--(Marketwired - May 26, 2016) - Microbion Corporation ("Microbion") of Bozeman, MT, USA and Microbion Pharma Corp. of Vancouver, BC, Canada, today announced that the U.S.
BOZEMAN, MT and VANCOUVER, BC--(Marketwired - March 01, 2016) - Microbion Corporation ("Microbion") of Bozeman, MT, USA and Microbion Pharma Corp. of Vancouver, BC, Canada, today announced that ...
BOZEMAN, Mont. and VANCOUVER, BC, Feb. 22, 2021 /PRNewswire/ — Microbion Corporation of Bozeman, MT, and Microbion Pharma Corp. of Vancouver, BC (“Microbion”) today announced that it has received ...
Microbion Corporation, a clinical-stage pharmaceutical company developing a new class of therapeutic compounds to improve the lives of patients with rare and serious diseases, announced that the ...
BOZEMAN, Mont. and VANCOUVER, British Columbia, Oct. 25, 2019 /PRNewswire/ -- Microbion Corporation of Bozeman, MT, and Microbion Pharma Corp. of Vancouver, BC ("Microbion") today announced that the ...
Pravibismane is the first of a new class of drugs with broad-spectrum potency against a wide range of pathogens, including NTM species Poster presentation highlighted the results from pravibismane in ...
Phase 2 study assesses safety and efficacy of topical pravibismane in subjects suffering from moderate infections associated with chronic diabetic foot ulcers In a previous Phase 1b randomized, double ...
BOZEMAN, MT, and VANCOUVER, BC--(Marketwired - June 16, 2016) - Microbion Corporation ("Microbion") of Bozeman, MT, USA and Microbion Pharma Corp. of Vancouver, BC, Canada, specializing in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results